Latest News
Press Releases
May 17, 2023
Zendal and IAVI announce expanded agreement to partner on development of TB vaccine candidate MTBVAC
March 2, 2023IAVI and BARDA expand partnership to advance IAVI’s filovirus vaccine candidates
December 2, 2022Scientists reveal encouraging findings in first-in-human clinical trial evaluating HIV vaccine approach
October 25, 2022IAVI to accelerate promising investigational Sudan ebolavirus vaccine development for potential outbreak research and response
August 31, 2022IAVI announces first vaccinations at Liberia site in Phase I clinical trial of Lassa fever vaccine candidate
Features
May 25, 2023
Novel HIV vaccine candidate stimulates immune response in T cells
May 10, 2023New IAVI paper makes the case for strengthening clinical and regulatory pathways to accelerate global access to monoclonal antibodies
April 28, 2023IAVI Board member Wafaa El-Sadr honored
March 30, 2023IAVI leaders to participate in World Vaccine Congress
March 27, 2023IAVI announces renewed support from the Danish government for its HIV prevention program
Media Contacts
North America
Rose Catlos
+1 212 847 1049
RCatlos@iavi.org
